Skip to main content

Day: October 13, 2025

Global Debut: EHang Introduces VT35, a Next-Generation Long-Range Pilotless Passenger eVTOL

HEFEI, China, Oct. 13, 2025 (GLOBE NEWSWIRE) — EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), a global leader in advanced air mobility (AAM) technology, today announced the launch of its new-generation long-range pilotless electric vertical take-off and landing (eVTOL) aircraft, the “VT35”. Building on the foundation of the earlier VT30 prototype, VT35 is an upgraded lift-and-cruise model designed for medium- to long-range applications including intercity, cross-sea, and cross-mountain transportation. With its autonomous flight capability, point-to-point efficiency, and eco-friendly electric propulsion, VT35 is set to play a pivotal role in advancing the low-altitude aerial mobility ecosystem from urban to intercity corridors. This launch not only marks a significant expansion of EHang’s...

Continue reading

Patrick Kalotis Joins Ingredion as EVP Global Texture & Healthful Solutions

WESTCHESTER, Ill., Oct. 13, 2025 (GLOBE NEWSWIRE) — Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage industry, today announced the appointment of Patrick Kalotis as executive vice president, Global Texture & Healthful Solutions, effective December 1, 2025. He will serve as a member of the executive leadership team and will report to Jim Zallie, president and chief executive officer. Kalotis will be responsible for developing the business strategy and driving the performance for the global Texture & Healthful Solutions segment. The role encompasses full ownership of the segment’s commercial and financial performance, and will partner closely with Global Innovation and Global Commercial Excellence to identify and capitalize on growth opportunities. “Patrick...

Continue reading

Anaptys Announces Late-Breaking Oral Presentation of Complete Phase 2b Data for Rosnilimab in Rheumatoid Arthritis at Upcoming ACR Convergence 2025

SAN DIEGO, Oct. 13, 2025 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that complete data from the Phase 2b trial of rosnilimab, a pathogenic T cell depleter, in rheumatoid arthritis (RA), was accepted for a late-breaking oral presentation at American College of Rheumatology (ACR) Convergence 2025 in Chicago, IL, Oct. 24 – 29, 2025. “We are honored to be selected by ACR to present our late-breaking Phase 2b data for rosnilimab in RA,” said Paul Lizzul, chief medical officer of Anaptys. “Being selected reinforces the transformational potential of rosnilimab, which delivered a compelling safety and tolerability profile and JAK-like efficacy through six months that was durable for at least three months off-drug. We...

Continue reading

MMA.INC Updates on Revolutionary Crypto and Web3 Platform to Convert 700 Million Global MMA Fans to Participants

HighlightsMMA.INC’s platform enables the community to ‘Get Paid to Train’ through tokenized rewards and cryptocurrency Expecting to release an MMA.INC utility token minted on the Solana Blockchain to facilitate payments and rewards on the MMA.INC platform Strategic partnership discussions underway including potential stablecoin integration Exploring the creation of a unique Digital Asset treasury (DAT) that diversifies assets and supports MMA.INC’s platform and upcoming utility token Establishing a panel of crypto experts to advise on crypto initiativesNew York, NY, Oct. 13, 2025 (GLOBE NEWSWIRE) — Mixed Martial Arts Group Limited (NYSE American: MMA) (“MMA” or the “Company” and doing business as MMA.INC), a technology driven ecosystem at the forefront of the global combat sports industry, today announced progress on the development...

Continue reading

PacBio HiFi Technology Selected as Core Platform for South Korea’s National Pangenome Project

More than 1,000 Korean genomes to be sequenced for global reference standards, advancing disease research and precision medicine MENLO PARK, Calif. and SEOUL, South Korea, Oct. 13, 2025 (GLOBE NEWSWIRE) — PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that its HiFi sequencing technology has been selected as the primary platform for the Korean Pangenome Reference Project, a landmark national initiative led by the Korea Disease Control and Prevention Agency (KDCA), National Institute of Health (KNIH). The project will generate the first large-scale, telomere-to-telomere quality reference genomes representing the Korean population and integrate the data into the global Human Pangenome Reference Consortium (HPRC). By building a more inclusive and comprehensive reference,...

Continue reading

NextNRG Reports Preliminary September 2025 Revenue Growth of 229% Year-Over-Year

MIAMI, Oct. 13, 2025 (GLOBE NEWSWIRE) — NextNRG, Inc. (NASDAQ: NXXT), a pioneer in AI-driven energy innovation transforming how energy is produced, managed, and delivered, today announced preliminary unaudited financial results for September 2025. September 2025 Highlights: Revenue: $7.07 million, up 229% year-over-year from $2.15 million in September 2024 Gallons Delivered: 2.03 million, up 238% year-over-year from 600,390 gallons in September 2024 Year-to-date revenue through September reached approximately $58.6 million, more than double full-year 2024 revenue of ~$27 million These results demonstrate the company’s continued expansion, with year-to-date revenue more than doubling all of 2024. The growth in gallons delivered reflects stronger utilization from both new and existing customers, confirming NextNRG’s ability...

Continue reading

Skyward Specialty to Host Third Quarter 2025 Earnings Call Thursday, October 30, 2025

HOUSTON, Oct. 13, 2025 (GLOBE NEWSWIRE) — Skyward Specialty Insurance Group, Inc.™ (NASDAQ: SKWD) (“Skyward Specialty” or “the Company”) expects to issue its third quarter 2025 earnings results after the market closes on Wednesday, October 29th which will be available on the Company website at investors.skywardinsurance.com/ under Quarterly Results. Skyward Specialty will host its earnings call to review the third quarter 2025 financial results on Thursday, October 30th at 12:00 p.m. EST. Investors may access the live audio webcast via the link on the Company’s investor site at investors.skywardinsurance.com/ under Events & Presentations. Additionally, investors can access the earnings call via conference call by registering via the conference link. Users will receive dial-in information and...

Continue reading

Research: Improved CEO-CIO Alignment Will Catalyze Strategic Decisions on AI Adoption

Adoption of AI is pushing CIOs into broader strategic roles, with greater responsibilities in transformation, cost control and workforce management However, 39% say they’re misaligned with their CEOs on key decisions 41% of CIOs say their business needs to invest more in IT infrastructure and 34% do not feel empowered by their CEO to make long-term IT strategy decisionsSANTA CLARA, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) — Netskope (NASDAQ: NTSK), a leader in modern security and networking for the cloud and AI era, today published new global research underscoring that CEO and CIO (Chief Information Officer) alignment plays a crucial role in the path to strategic AI adoption. While organizational enthusiasm for the promise of AI is seeing CIOs take on broader, more strategic responsibilities, many are seeking stronger support...

Continue reading

OpenAI and Broadcom announce strategic collaboration to deploy 10 gigawatts of OpenAI-designed AI accelerators

Multi-year partnership enables OpenAI and Broadcom to deliver accelerator and network systems for next-generation AI clusters News:OpenAI and Broadcom will co-develop systems that include accelerators and Ethernet solutions from Broadcom for scale-up and scale-out Broadcom to deploy racks of AI accelerator and network systems targeted to start in the second half of 2026, to complete by end of 2029SAN FRANCISCO and PALO ALTO, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) — OpenAI and Broadcom Inc. (NASDAQ: AVGO) today announced a collaboration for 10 gigawatts of custom AI accelerators. OpenAI will design the accelerators and systems, which will be developed and deployed in partnership with Broadcom. By designing its own chips and systems, OpenAI can embed what it’s learned from developing frontier models and products directly into...

Continue reading

Professional Diversity Network, Inc. Established a Japanese Subsidiary, Launching a New Phase of Its Asia Strategy and Global Expansion

CHICAGO, Oct. 13, 2025 (GLOBE NEWSWIRE) — Professional Diversity Network, Inc. (Nasdaq: IPDN) (“IPDN” or the “Company”), a technology holding company focused on the application of AI technologies and AI-powered solutions, today announced the establishment of a wholly owned subsidiary in Tokyo, Japan. This marks a significant milestone in the Company’s ongoing globalization strategy, and further strengthens its presence in Asia, with Japan serving as the central hub for business development, technological innovation, and strategic collaboration throughout the region. The newly established IPDN’s Japanese subsidiary will serve as the group’s regional headquarter for Web3.0 and entertainment-related initiatives in Asia, focusing on the following four key strategic areas: Real-World Asset Tokenization (RWA): Driving the digital transformation...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.